PACE GARY W 4
4 · Pacira BioSciences, Inc. · Filed May 15, 2023
Insider Transaction Report
Form 4
PACE GARY W
Director
Transactions
- Exercise/Conversion
Common Stock
2023-05-11$29.90/sh+7,000$209,300→ 144,690 total - Sale
Common Stock
2023-05-11$41.78/sh−5,015$209,527→ 139,675 total - Exercise/Conversion
Stock Option (Right to Buy)
2023-05-11−7,000→ 0 totalExercise: $29.90Exp: 2023-06-12→ Common Stock (7,000 underlying)
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.75 to $41.85, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F2]The stock option vested and became exercisable in twelve equal monthly installments, with the first installment being on July 12, 2013.